Relationship between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome;A hypothalamus-hypophysis-mellékvese tengely és a metabolikus szindróma kapcsolata

Orvosi Hetilap

Volumn 146, Issue 2, 2005, Pages 51-55

  Góth, Miklós ^a   Hubina, Erika ^a   Korbonits, Márta ^b  

^a Endokrinológiai Szakprofil ^*  (Hungary)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Carbohydrate metabolism; Dyslipidemia; Hypothalamo pituitary adrenal axis; Metabolic syndrome; Obesity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE;

ADIPOSE TISSUE; ARTICLE; CLINICAL FEATURE; CUSHING SYNDROME; DISEASE ASSOCIATION; DYSLIPIDEMIA; FETAL MALNUTRITION; HORMONE METABOLISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN EXPRESSION; ADRENAL TUMOR; ADULT; ANIMAL; BIOSYNTHESIS; BIRTH WEIGHT; CORONARY ARTERY DISEASE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HYPOPHYSIS ADRENAL SYSTEM; INFANT MORTALITY; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MORTALITY; NEWBORN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ADRENAL GLAND NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ADULT; ANIMALS; BIRTH WEIGHT; CORONARY DISEASE; CORTISONE; DIABETES MELLITUS, TYPE 2; FETAL NUTRITION DISORDERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCORTISONE; HYPERLIPIDEMIAS; HYPERTENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT MORTALITY; INFANT, NEWBORN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PITUITARY-ADRENAL SYSTEM; PREVALENCE;

EID: 14744269392     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barker, D. J., Osmond, C.: Infant mortality, childhood nutrition and ischaemic heart disease in England and Wales. Lancet, 1986, 1, 1077-1081.
2. Barker, D. J., Winter, P. D., Osmond, C. és mtsai: Weight in infancy and death from ischaemic heart disease. Lancet, 1989, 2, 577-580.
3. Barker, D. J., Hales, C. N., Fall, C. H. D. és mtsai: Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia, 1993, 36, 62-67.
4. Barker, D. J.: Fetal origins of cardiovascular disease. Ann. Med., 1999, 31 (Suppl. 1.), 3-6.
5. Bertram, C. E., Hanson, M. A.: Prenatal programming of postnatal endocrine responses by glucocorticoids. Reproduction, 2002, 124, 459-467.
6. Bhargava, S. K., Sachdev, H. S., Fall, C. H. D. és mtsai: Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N. Engl. J. Med., 2004, 350, 865-875.
7. Bujalska, I. J., Kumar, S., Stewart, P. M.: Does central obesity reflect "Cushing's disease of the omentum"? Lancet, 1997, 349, 1210-1213.
8. Byrne, C. D.: Programming other hormones that affect insulin. Br. Med. Bull., 2001, 60, 153-171.
9. Fall, C. H. D., Osmond, C., Barker, D. J. P. és mtsai: Fetal and infant growth and cardiovascular risk factors in women. Br. Med. J., 1995, 310, 428-423.
10. Fall, C. H. D., Dennison, E., Cooper, C. és mtsai: Does birth weight predict adult serum cortisol concentrations? Twenty-four-hour profiles in the United Kingdom 1920-1930 Herfordshire Birth Cohort. J. Clin. Endocrinol. Metab., 2002, 87, 2001-2007.
11. Hales, C. N., Barker, P. J., Clark, P. M. és mtsai: Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J., 1991, 303, 1019-1022.
12. Jones, S. E., Nyengaard, J. R.: Low birth weight and cardiovascular disease: myth or reality? Curr. Opin. Lipidol., 1998, 9, 309-312.
13. Kajentie, E., Phillips, D. I. W., Andersson, S. és mtsai: Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper- and hypocortisolism? Clin. Endocrinol., 2002, 57, 635-641.
14. Khani, S., Tayek, J. A.: Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin. Sci., 2001, 101, 739-747.
15. Klebanoff, M. A., Secher, N. J., Mednick, B. R. és mtsa: Maternal size at birth and the development of hypertension during pregnancy: a test of the Barker hypothesis. Arch. Intern. Med., 1999, 159, 1607-1612.
16. Lithell, H. O., McKeigue, P. M., Berglund, L. és mtsai: Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in man aged 50-60 years. Br. Med. J., 1996, 312, 406-410.
17. Lumbers, E. R., Yu, Z. Y., Gibson, K. J.: The selfish brain and the Barker hypothesis. Clin. Exp. Pharmacol. Physiol., 2001, 28, 942-947.
18. Mantero, F., Terzolo, M., Arnaldi, G. és mtsai: A survey on adrenal incidentaloma in Italy. J. Clin. Endocrinol. Metab., 2000, 85, 637-644.
19. Peters, A., Schweiger, U., Frühwald-Schultes, B. és mtsai: The neuroendocrine control of glucose allocation. Exp. Clin. Endocr. Diab., 2002, 110, 199-211.
20. Phillips, D. I. W., Barker, D. J. P., Hales, C. N. és mtsa: Thinness at birth and insulin resistance in adult life. Diabetologia, 1994, 37, 150-154.
21. Phillips, D. I., Barker, D. J., Fall, C. H. és mtsai: Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab., 1998, 83, 757-760.
22. Poston, L.: Intrauterine vascular development programming effects of nutrition on vascular function in the new born and adult. Nutr. Health., 2001, 15, 207-212.
23. Poulter, N. E.: Birthweights, maternal cardiovascular events, and Barker hypothesis. Lancet, 2001, 357, 1990-1991.
24. Rask, E., Walker, B. R., Söderberg S. és mtsai: Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab., 2002, 87, 3330-3336.
25. Reynolds, R. M., Walker, B. R., Syddall, H. E. és mtsai: Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab., 2001, 86, 245-250.
26. Rossi, R., Tauchmanova, A., Luciano, A. és mtsai: Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metab., 2000, 85, 1440-1448.
27. Terzolo, M., Pia, A., Ali, A. és mtsai: Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metab., 2002, 87, 998-1003.
28. Tauchmanova, L., Rossi, R., Biondi, B. és mtsai: Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab., 2002, 87, 4872-4878.
29. Ward, A. M. V., Fall, C. H. D., Stein, C. E. és mtsai: Cortisol and the metabolic syndrome in South Asians. 2003, Clin. Endocrinol., 58, 500-505.
30. Ward, A. M. V., Syddall, H. E., Wood, P. J. és mtsai: Fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis: low birth weight and central HPA regulation. 2004, J. Clin. Endocrinol. Metabolism., 89, 1227-1233.
31. Waterland, R. A.: Transposable elements: targets for early nutritional effects on epigenetic gene regulation. 2003, Mol. Cell Biol., 23, 5293-5300.